Home / Gadobutrol / United States
US ATC V08CA09 · updated 2 Nov 2026
Gadobutrol shortage in United States
Is there a Gadobutrol shortage in United States?
Yes. As of 2 Nov 2026, 4 Gadobutrol products are reported short in United States, the first since 30 Jun 2026. No return date has been given. Main reason: not stated.
Also short in Italy, Belgium, Sweden, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02) discontinuation | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 30 Jun 2026 | not given | Not stated |
| US | Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-07) discontinuation | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 30 Jun 2026 | not given | Not stated |
| US | Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-10) discontinuation | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 30 Jun 2026 | not given | Not stated |
| US | Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-15) discontinuation | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 30 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).